Maricann Group Inc Share Price Deutsche Boerse AG
Equities
CA5667241007
Pharmaceuticals
Sales 2016 | 4.06 3.74 338.51 | Sales 2017 | 3.22 2.96 268.69 | Capitalization | 203M 187M 16.94B |
---|---|---|---|---|---|
Net income 2016 | -8M -7.36M -667M | Net income 2017 | -67M -61.64M -5.59B | EV / Sales 2016 * | - |
Net Debt 2016 | 9.13 8.4 761.04 | Net cash position 2017 | 0.42 0.38 34.86 | EV / Sales 2017 | 6,30,46,727 x |
P/E ratio 2016 * |
-
| P/E ratio 2017 |
-2.13
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Dan Healey
COO | Chief Operating Officer | - | - |
Steven Bennett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
1st Jan change | Capi. | |
---|---|---|
+38.97% | 6.09B | |
-22.28% | 4.14B | |
+3.48% | 3.23B | |
-19.51% | 2.83B | |
-7.29% | 2.39B | |
+42.43% | 1.9B | |
-4.71% | 1.57B | |
-15.15% | 1.55B | |
-14.86% | 1.5B |